Director, National PEL Lead

Overview

Reporting to the Senior Director, US Patient Services, we seek an experienced, patient-focused individual to work remotely and lead a field-based team of Patient Education Liaisons (PELs). The Patient Education Liaison (PEL) team is a critical component of the Alnylam commercial strategy and work in close coordination with Field Sales, Field Reimbursement, Patient Services Hub, and Patient Advocacy Teams to support Alnylam's patient-focused vision of harnessing a revolution in biology for human health.

The PEL team will be responsible for educating patients, caregivers, families, and community groups affected by, or at risk for, hATTR amyloidosis, acute hepatic porphyria (AHP) and primary hyperoxaluria (PH), on the genetic aspects of the disease and on onpattro, amvuttra, givosiran and lumasiran, and Alnylam's services, through phone-based or in-person meetings. A key role of the team will be to provide in-depth education about hATTR amyloidosis/AHP/PH1, the inherited nature, available diagnostic options, and the significance of early treatment. Team members will also be responsible for engaging with select healthcare providers within their geographic region.

The successful candidate must be passionate about science and deeply motivated by the quest of delivering value to patients and their families with the long-term success of the company in mind. He/she will set strategy, work collaboratively with internal and external colleagues to build tactical plans, and build a seasoned, highly trained team to execute the strategic imperatives. This individual will also deliver a positive patient and healthcare provider experience by assessing needs and developing action plans that identify and troubleshoot barriers to support treatment initiation and ensure continuity of care throughout the patient treatment journey.

Key Responsibilities

• Works collaboratively with all Program Brand Leads, Marketing, Field Sales, Patient Services Hub, Medical Affairs, Advocacy and other critical functions to establish critical success factors and objectives for PEL team
• Identify, develop and lead opportunities for key strategic partnerships with relevant societies and conferences to support insight generation, educational outreach and strong external collaboration
• Leads strategic and tactical planning for PEL team to provide disease, inheritance, and product education and support to patients and their families/caregivers
• Hires, onboards, and sustains a high-performing and diverse team of experienced Nursing Professionals and develops ongoing training plans
• Establishes targeted workplans for regional team members
• Develops KPIs and reporting dashboards to track critical business metrics
• Provides comprehensive updates on activity to regional colleagues, ensuring that the regional team is working seamlessly as one entity
• Offers constructive feedback on existing workplan and proposes innovative service offerings to leadership where opportunities exist
• Participate in the development of materials that increase provider and patient/caregiver awareness of Alnylam's patient support services

• Deliver on key objectives established annually and demonstrate accountability for execution and drive results
• Actively contributes to the annual business/brand planning process with Marketing and leadership
• Prepare key deliverables for appropriate internal stakeholders
• Represent patients and their families within Alnylam, helping us to meet their needs
• Maintains disease, diagnostic testing, and product expertise through continuing medical education and attendance at relevant symposia, conferences and other educational opportunities
• Participate in overall Patient Services budget management
• Participate on various cross-functional teams, representing the US Patient Services team
• Overall team performance management, including coaching, training, development and evaluation
• Ensures compliance with all corporate and industry policies per training provided by Alnylam Commercial, Legal, Regulatory and Compliance Officers

Qualifications

• Bachelor of Science, Registered Nurse or other relevant clinical/medical degree required
• 5 years Pharmaceutical/biotech experience required
• 5 yrs. managing highly effective, cross-functional teams
• 7 yrs. prior experience working as a nurse or patient educator required
• Strong leadership abilities with demonstrated experience in leading and coaching teams
• A proven track record of successful project delivery and positive performance results
• Experience supporting and providing education to patients and family members affected by rare genetic diseases or other chronic illnesses a plus
• Exceptional interpersonal skills, professional communications, problem-solving, compassion and the ability to navigate difficult conversations
• Ability to translate scientific/medical information into patient-friendly language
• Ability to work well and lead within with cross-functional groups and in a matrix organization
• Models and fosters team effectiveness by sharing knowledge, experience, and information across departmental boundaries
• Quality driven approach with attention to detail and accuracy
• Strong organizational skills and ability to adapt to change and react constructively in a high-energy and fast paced environment.
• Desire to innovate and work in a fast-paced, energetic environment
• Self-starter who is highly passionate about rare disease and Alnylam's core values:
• Commitment to People, Innovation, Discovery, Purposeful Urgency, Open Culture, and Passion for Excellence.
• Ability to travel to home office a minimum of 2 days /week as needed and during pertinent meetings

About Alnylam

Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.